Locoregional Recurrence Risk in Breast Cancer Patients with Estrogen Receptor Positive Tumors and Residual Nodal Disease following Neoadjuvant Chemotherapy and Mastectomy without Radiation Therapy

Locoregional Recurrence Risk in Breast Cancer Patients with Estrogen Receptor Positive Tumors and Residual Nodal Disease following Neoadjuvant Chemotherapy and Mastectomy without Radiation Therapy

Among breast cancer patients treated with neoadjuvant chemotherapy (NAC) and mastectomy, locoregional recurrence (LRR) rates are unclear in women with ER+ tumors treated with adjuvant endocrine therapy without postmastectomy radiation (PMRT). To determine if PMRT is needed in these patients, we comp...

Full description

Saved in:
Bibliographic Details
Main Authors: Shravan Kandula, Jeffrey M. Switchenko, Saul Harari, Carolina Fasola, Donna Mister, David S. Yu, Amelia B. Zelnak, Mylin A. Torres
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:International Journal of Breast Cancer
Online Access:http://dx.doi.org/10.1155/2015/147476
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items